Pricing

Morphic Therapeutic

1 follower

‌

Morphic Therapeutic is leading the development of a new generation of oral integrin drugs, informed by decades of world-leading expertise and a unique integrin discovery platform.

Industries

Pharmaceutical

Headquarters

Waltham, United States

Employees

51-200

Links

Org chart

Praveen Tipirneni

President & CEO

Praveen Tipirneni

Collapse

Marc Schegerin

CFO & COO

Bruce Rogers

President

Chris Erdman

Senior Vice President, Investor Relations & Corporate Communications

Joanne Gibbons

SVP, Regulatory & Quality

Hanh Nguyen

SVP, Technical Operations

Brihad Abhyankar

Vice President, Clinical Development

Carolyn Soo

Vice President, Clinical Operations

Matt Bursavich

VP, Chemical Sciences

Board & advisors

Amir Nashat

Director

Gustav Christensen

Director

Norbert Bischofberger

Director

Director

Director

Director

Advisor

Scientific Advisor

Scientific Advisor

Director

Ulrich H. Von Andrian

Scientific Advisor

Yury V. Popov

Scientific Advisor

Silvio Danese

Clinical Advisor

Laurent Peyrin-Biroulet

Clinical Advisor

Brian G. Feagan

Clinical Advisor

Bruce Sands

Clinical Advisor

Stefan Schreiber

Clinical Advisor

Teams

+17

Scientific and Clinical Research Team

20 members

Director

12 members

Clinical Operations Team

10 members

Corporate Management & Operations Team

5 members

Scientific & Clinical Development Team

5 members

Leadership Team

3 members

Offices

Similar companies

Azurity Pharmaceuticals

6 followers

Empower Pharmacy

5 followers

Ocular Therapeutix

2 followers

BioCryst Pharmaceuticals

2 followers

Crinetics Pharmaceuticals

1 follower

Providence Medical Technology

1 follower

NS Pharma, Inc.

2 followers

Phil

2 followers

Bristol-Myers Squibb

209 followers

VIRIXENE

123 followers

Alnylam Pharmaceuticals

23 followers

Explore companies